This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Locanabio, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Rea Lardelli Markmiller in San Diego, CA
Introduction
Rea Lardelli Markmiller is an accomplished inventor located in San Diego, California, known for his innovative contributions in the field of biotechnology. He holds a patent that demonstrates his expertise in engineered short nuclear RNA systems, showcasing the potential for advancements in genetic research and treatment methodologies.
Latest Patents
Rea Lardelli Markmiller's notable patent, entitled "Compositions and methods comprising engineered short nuclear RNA (snRNA)," discloses systems that incorporate engineered stem loops. This invention signifies a significant stride in the understanding and application of RNA mechanisms, offering potential benefits in therapeutic applications.
Career Highlights
Currently, Rea Lardelli Markmiller is associated with Locanabio, Inc., a company dedicated to harnessing the power of RNA to treat genetic diseases. His work here emphasizes the integration of scientific research with practical applications, striving to make a real-world impact in medicine and biotechnology.
Collaborations
Rea has collaborated closely with fellow researchers such as Ranjan Batra and Rachel A. Adams. Together, they contribute to the innovative environment at Locanabio, Inc., where teamwork fuels the development of groundbreaking solutions in RNA research and therapies.
Conclusion
Rea Lardelli Markmiller's contributions to the field of biotechnology, particularly through his patent on engineered short nuclear RNA, highlight his role as a significant innovator in genetic research. With collaborative efforts with esteemed colleagues, his work continues to pave the way for advancements that could transform healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile